Petros Syrris

University College London
Country flagUnited Kingdom
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Protein-glutathionylation is traditionally viewed as a protective mechanism that shields cysteine-residues from irreversible oxidative damage. Its broader functional roles remain poorly understood, in part due to technical limitations in detecting this modification at scale. Here, we develop and leverage a new mass-spectrometry approach that preserves protein-glutathionylation, thereby revealing its widespread distribution across the proteome in cell models, worms, mice and human cardiac tissues. In all cases, we find that glutathionylation sites are enriched at both protein-protein interfaces and protein-active sites, and are highly conserved across species. We find that glutathionylation is dynamically redistributed in response to environmental challenges, thereby driving remodelling of cellular protein–protein interaction (PPI) networks, and access to protein active sites, with functional and phenotypic consequences. Finally, we show that glutathionylation accumulates on key cardiac-sarcomeric proteins in aged-mice and human cardiomyopathy biopsies, revealing its role in cardiovascular dysfunction. These findings reposition glutathionylation as a crucial regulatory PTM, akin to phosphorylation, that orchestrates adaptive cellular responses. This work redefines the role of glutathionylation, with broad implications for cell biology and disease.

Year:

2026

Background Desmoplakin (DSP) cardiomyopathy, caused by variants in the gene DSP , is a unique subtype of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathies. Specific diagnostic and disease staging criteria have yet to be developed for DSP cardiomyopathy. Objective Utilizing a large cohort of DSP cardiomyopathy patients and their genotype-positive family members, this study aims to develop diagnostic and disease staging criteria for DSP cardiomyopathy. Methods Patients from the DSP -ERADOS Network with complete rhythm monitoring, electrocardiogram and cardiac magnetic resonance imaging were enrolled. Diagnostic criteria were assessed in initially-presenting patients (probands) and their genotype-positive family members. Early disease criteria (with preserved left ventricular ejection fraction, LVEF) were integrated into standard LVEF-based classifications. Diagnostic and staging criteria were assessed by time-event analyses (major ventricular arrhythmia and heart failure events). Results A total of 605 patients with complete diagnostic testing were included (mean age 40 yr, 60% female, 40% probands). The most prevalent disease features in probands were premature ventricular contractions (PVCs) >500/24hr (66%), nonsustained ventricular tachycardia (NSVT, 29%), LV late gadolinium enhancement (LGE, 53%), and reduced LVEF (44%). The presence of any one of these features was 97% sensitive for diagnosis (along with a DSP pathogenic variant) and were therefore considered as diagnostic criteria. Using these criteria, 77% of genotype-positive family members were considered clinically affected. Isolated right ventricular (RV) involvement occurred in only 0.7%. The absence of diagnostic criteria identified a low-risk group (composite event rate 0.8%/year, p 50%, HR 2.7, p=0.04; intermediate: LVEF 41-49%, HR 3.7, p=0.009; advanced: LVEF <40% HR 10.3, p<0.001). LGE was mostly subepicardial (87%). Circumferential (ring-like) LGE was more frequent in intermediate or advanced vs early disease (66% vs 48%, p<0.001). Conclusion This study identifies genotype-specific diagnostic and disease staging criteria for DSP cardiomyopathy that improve identification of risk for both heart failure and sustained ventricular arrhythmias. This work highlights how gene-specific criteria may be used to refine diagnosis and staging for cardiomyopathy subtypes – a critical step as gene-targeted treatments move toward clinical trials.

Year:

2025

Snap frozen biopsies serve as a valuable clinical resource of archival material for disease research, as they enable a comprehensive array of downstream analyses to be performed, including extraction and sequencing of nucleic acids. Obtaining three-dimensional (3D) structural information prior to multi-omics is more challenging but could potentially allow for better characterisation of tissues and targeting of clinically relevant cells. Conventional histological techniques are limited in this regard due to their destructive nature and the reconstruction artifacts produced by sectioning, dehydration, and chemical processing. These limitations are particularly notable in soft tissues such as the heart. In this study, we assessed the feasibility of using synchrotron-based cryo-X-ray phase contrast imaging (cryo-X-PCI) of snap frozen myocardial biopsies and 3D structure tensor analysis of aggregated myocytes, followed by nucleic acid (DNA and RNA) extraction and analysis. We show that optimal sample preparation is the key driver for successful structural and nucleic acid preservation which is unaffected by the process of cryo-X-PCI. We propose that cryo-X-PCI has clinical value for 3D tissue analysis of cardiac and potentially non-cardiac soft tissue biopsies prior to nucleic acid investigation.

Year:

2024

Collaborators (33)

Arthur A M Wilde

University of Amsterdam

NETHERLANDS
View details

Nisha Gilotra

Assistant Professor of Medicine

Johns Hopkins University School of Medicine

UNITED STATES
View details

Firat Duru

-

SWITZERLAND
View details

Andrew Cook

University College London

UNITED KINGDOM
View details

Kristina Haugaa

Professor

University of Oslo

NORWAY
View details

A.s Amin

Cardiologist

Amsterdam University Medical Centers

NETHERLANDS
View details

Eric Smith

University of Michigan

UNITED STATES
View details

Julia Cadrin-Tourigny

Clinical Assistant Professor

Université de Montréal

CANADA
View details

J. Peter van Tintelen

Head Department; clinical geneticist

Universitair Medisch Centrum Utrecht

NETHERLANDS
View details

Matthew Taylor

Professor

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Lia Crotti

Director of the Cardiological Rehabilitation Unit, San Luca Hospital

IRCCS Istituto Auxologico Italiano

ITALY
View details

Victoria N. Parikh

Stanford University

UNITED STATES
View details

Vishwanie Budhram-Mahadeo

Professor

University College London

UNITED KINGDOM
View details

Sing-Chien Yap

Researcher

Erasmus University Rotterdam

NETHERLANDS
View details

Michela Casella

Researcher

Università Politecnica delle Marche

ITALY
View details

Adam Helms

Assistant Professor

University of Michigan

UNITED STATES
View details

James Ware

Professor

Imperial College London

UNITED KINGDOM
View details

Marco Merlo

University of Trieste

ITALY
View details

Konstantinos Thalassinos

University College London

UNITED KINGDOM
View details

Marina Cerrone

Research Assistant Professor of Medicine

NYU School of Medicine

UNITED STATES
View details

Gianfranco Sinagra

University of Trieste

ITALY
View details

Barbara Bauce

Associate Professor

University of Padova

ITALY
View details

Hugh Calkins

Johns Hopkins University School of Medicine

UNITED STATES
View details

Cynthia James

Associate Professor

Johns Hopkins University

UNITED STATES
View details

cristina basso

Professore Ordinario di Anatomia Patologica

University of Padova

ITALY
View details

Kalliopi Pilichou

Associate Professor

University of Padua

ITALY
View details

Ardan M. Saguner

-

SWITZERLAND
View details

Luisa Mestroni

Professor of Medicine

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Juan Gimeno Blanes

Associate Professor

Universidad de Murcia

SPAIN
View details

Kan Yan Chloe Li

Postgraduate Teaching Assistant

University College London

UNITED KINGDOM
View details

Marco Schiavone

Clinical Scientist

Centro Cardiologico Monzino

ITALY
View details

Giovanni Peretto

Vita-Salute San Raffaele University

ITALY
View details

Perry Elliott

University College London

UNITED KINGDOM
View details